Materials and methods for nerve repair
View Patent ↗The subject invention pertains to compositions and methods for promoting repair of damaged nerve tissue. The compositions and methods of the subject invention can be employed to restore the continuity of nerve interrupted by disease, traumatic events or surgical procedures. Compositions of the subject invention comprise one or more chondroitin sulfate proteoglycan (CSPG)-degrading enzymes that promote axonal penetration into damaged nerve tissue. The invention also concerns methods for promoting repair of damaged nerve tissue using the present compositions and nerve tissue treated according to such methods. The invention also pertains to kits for nerve repair.
1. A surgical cuff to promote repair of a damaged nerve of the peripheral nervous system, wherein said cuff comprises at least one chondroitin sulfate proteoglycan-degrading enzyme selected from the group consisting of chondroitinase ABC, chondroitinase A, chondroitinase C, chondroitinase AC, matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9), and a sleeve to be applied to a nerve graft or damaged nerve of the peripheral nervous system.
2. The surgical cuff of claim 1 , wherein said sleeve comprises a tube, and wherein said tube defines a lumen for insertion of a nerve graft or damaged nerve.
3. The surgical cuff of claim 2 , wherein said tube has a slit extending longitudinally along the length of said tube, wherein said slit has first and second abutting edges, and wherein said first abutting edge is in separable contact with said second abutting edge, and wherein said first and second abutting edges can be separated to expose said lumen.
4. The surgical cuff of claim 1 , wherein said surgical cuff further comprises means for delivering said chondroitin sulfate proteoglycan-degrading enzyme to the damaged nerve.
5. The surgical cuff of claim 4 , wherein said chondroitin sulfate proteoglycan-degrading enzyme delivering means comprises a polymer.
6. The surgical cuff of claim 1 , wherein said sleeve is biodegradable.
7. The surgical cuff of claim 1 , wherein said cuff further comprises living cells seeded upon said sleeve.
8. The surgical cuff of claim 7 , wherein said living cells comprise Schwann cells.
9. The surgical cuff of claim 7 , wherein said living cells are genetically modified with a polynucleotide expressing said chondroitin sulfate proteoglycan-degrading enzyme.
10. The surgical cuff of claim 1 , wherein said sleeve has a facing surface for contacting said nerve graft or said damaged nerve, and wherein said cuff further comprises a tissue adhesive on at least a portion of said facing surface.